How Much Did NewLimit Raise? Funding & Key Investors

Date November 19, 2026
N

NewLimit

COMPANY INFO

NewLimit develops medicines intended to extend human healthspan by restoring youthful function in aged cells. It uses epigenetic reprogramming, AI-based design and genomic experiments to discover potential therapies, initially focused on liver, immune-system and vascular conditions.

What is Exa?

This page is built with Exa, a web search API for AI agents. It is updated every 24 hours.

How Much Did NewLimit Raise? Funding Rounds and Investors

NewLimit develops medicines intended to extend human healthspan by restoring youthful function in aged cells. It uses epigenetic reprogramming, AI-based design and genomic experiments to discover potential therapies, initially focused on liver, immune-system and vascular conditions.

Official website: https://www.newlimit.com

NewLimit has raised $650 million across 4 funding rounds.

Funding Rounds

Series A - $40 million - May 2023

NewLimit announced Series A financing. Led by Dimension, Founders Fund and Kleiner Perkins.

Series B - $130 million - May 2025

Kleiner Perkins led the financing; NFDG, Khosla Ventures, Human Capital and Valor Equity Partners joined as new investors. Led by Kleiner Perkins.

Additional financing - $45 million - October 2025

NewLimit announced additional financing from Eli Lilly and Company, Duke Management Co., Section 32 and others on a $1.62 billion cap; it did not name a lead investor.

Series C - $435 million - June 2026

NewLimit announced its Series C with new investors Thrive Capital, Greenoaks and Quiet Capital. Led by Founders Fund.

Key Investors

  • Founders Fund
  • Kleiner Perkins
  • Dimension
  • Thrive Capital
  • Greenoaks
  • Quiet Capital
  • Khosla Ventures
  • Human Capital
  • Valor Equity Partners
  • Eli Lilly and Company

Find funding data on any company with Websets!

Websets is a powerful natural language search and data enrichment tool that helps you discover comprehensive funding information for any company. Whether you're researching NewLimit funding rounds or exploring investment data for other companies, Websets provides detailed insights into funding history, investors, and financial milestones.

With Websets, you can access detailed funding profiles, investor information, and financial data through intuitive natural language queries. Sign up now to enhance your funding research capabilities.

What is Exa?

This page is built with Exa, a web search API for AI agents. It is updated every 24 hours.

Exa searches the web, extracts relevant source content, and returns structured outputs with citations.

How it works

API request

Preview
TypeScript
const run = await exa.agent.runs.create({
  query: "Research Newlimit's funding rounds, key investors, total raised, and latest funding date. Return structured JSON with field-level citations.",
  effort: "low",
  outputSchema: {
    // company, fundingRounds, keyInvestors, totalRaised
    /* ... */
  }
});

const result = await exa.agent.runs.pollUntilFinished(run.id);
Copy request preview

API output

Preview
JSON
{
  "status": "completed",
  "output": {
    "structured": {
      "company": "Newlimit",
      "fundingRounds": [
        "..."
      ],
      "keyInvestors": [
        "..."
      ],
      "totalRaised": "$650 million"
    },
    "grounding": [
      {
        "field": "fundingRounds[0].amount",
        "citations": [
          {
            "url": "..."
          }
        ]
      }
    ]
  }
}
Copy output preview